本期内容提示:
1、此前推的逆向并购概念股$Aerpio制药(ARPO)$ 宣布了并购,后续是否还有行情?哪些标的还有类似的潜力?
2、又一双抗药物平台获得多家机构建仓,是否有投资机会?
3、$Seelos Therapeutics(SEEL)$ 数据不错,缘何大跌,是否有抄底机会...查看全文
Seelos Therapeutics盘前跌4.25%,报0.153美元。消息上,在Seelos Therapeutics公布了SLS-002治疗抑郁症的2期临床试验数据后,Cantor Fitzgerald将该公司的评级从“增持”下调至“中性”,同时没有... 网页链接
$Seelos Therapeutics(SEEL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001136261-22-000156 Act: 34 Size: 6 MB 网页链接
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-22-000155 Size: 4 KB 网页链接
$Seelos Therapeutics(SEEL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-018531 Act: 34 Size: 13 KB 网页链接
$Seelos Therapeutics(SEEL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-007321 Act: 34 Size: 13 KB 网页链接
$Seelos Therapeutics(SEEL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001136261-22-000048 Act: 33 Size: 123 KB 网页链接
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-22-000041 Size: 5 KB 网页链接
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-22-000042 Size: 11 KB 网页链接
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001136261-22-000035 Act: 34 Size: 304 KB 网页链接
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-22-000019 Size: 5 KB 网页链接
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-22-000020 Size: 5 KB 网页链接